Home/TauC3 Biologics/Michael P. Ross, PhD, CFA

MP

Michael P. Ross, PhD, CFA

Board Member

TauC3 Biologics

Therapeutic Areas

Neurodegenerative Diseases Frontotemporal Dementia Progressive Supranuclear Palsy

TauC3 Biologics Pipeline

Drug	Indication	Phase
Undisclosed Tau Immunotherapy	Tau-related Frontotemporal Dementia (FTD-tau)	Pre-clinical

Leadership Team at TauC3 Biologics

Bia Goncalves, PhD

Director of Scientific Communications

Scott Pollack, PhD

Scientific Leader (implied)

Chief Financial Officer

Shafique Virani, MD

Richard A. Margolin, MD

Daniel G. Chain, PhD

Director/Scientific Founder

View full TauC3 Biologics profile